Simvastatin inhibited NLRP3 inflammasome activation and ameliorated lung injury in hyperoxia-induced BPD via Kruppel-like factor 2 (KLF2)-mediated mechanism [157]. The gene discussed is NLRP3; the disease is bronchopulmonary dysplasia.